Pubmed Data : Anticancer Res. 2017 04 ;37(4):1705-1710. PMID: 28373432
Article Published Date : Dec 31, 2016
Study Type : In Vitro Study
Additional Links
Substances : Myricetin
Diseases : Thyroid Cancer
Pharmacological Actions : Antiproliferative , Apoptotic, Bcl-2 protein down-regulation, Cell cycle arrest